(Q37284239)

English

Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer

scientific article published on October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

2

object named as

Pasi A Jänne

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

Luca Toschi

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

language of work or name

0 references

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

5941-5946

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

10.1158/1078-0432.CCR-08-0071

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37284239&oldid=2186770839"